首页 > 最新文献

Innovations in pharmacy最新文献

英文 中文
Using 15-Minute Serial Blood Pressures as an Alternative to Measuring a Single Blood Pressure. 使用 15 分钟连续血压测量法替代单次血压测量法。
Pub Date : 2023-11-20 eCollection Date: 2023-01-01 DOI: 10.24926/iip.v14i4.5565
Ann M Philbrick, Caroline S Carlin, Ila M Harris, Christopher Fallert

Thirty-minute office blood pressure (OBP-30) is an alternative to ambulatory blood pressure (BP) measurement, yet is impractical to implement. This study aimed to determine whether unattended BP readings over 15 minutes would result in a similar probability of obtaining a BP of <140/90. Sixty-seven adults self-described as having high BP were analyzed. BP was measured at baseline and every 5 minutes for 15 minutes with the initial reading compared to the average of the last three readings (OBP-15). Compared to baseline, there was a decline in both average systolic (4.2 points) and diastolic (2.8 points) BP. The probability of BP control predicted by multivariate model was 71.6% at baseline and 78.0% using OBP-15 (p=0.011). The increase in BP control from initial to OBP-15 measurement was significant for indigenous or persons of color compared to whites, and men compared to women. OBP-15 is convenient and results in lower BP readings and higher probability of BP control compared to the initial reading.

30 分钟办公室血压(OBP-30)是门诊血压(BP)测量的替代方法,但实施起来并不现实。本研究旨在确定在 15 分钟内无人值守的情况下读取血压值是否会导致类似的概率,即在 30 分钟内读取的血压值与在办公室内读取的血压值相等。
{"title":"Using 15-Minute Serial Blood Pressures as an Alternative to Measuring a Single Blood Pressure.","authors":"Ann M Philbrick, Caroline S Carlin, Ila M Harris, Christopher Fallert","doi":"10.24926/iip.v14i4.5565","DOIUrl":"10.24926/iip.v14i4.5565","url":null,"abstract":"<p><p>Thirty-minute office blood pressure (OBP-30) is an alternative to ambulatory blood pressure (BP) measurement, yet is impractical to implement. This study aimed to determine whether unattended BP readings over 15 minutes would result in a similar probability of obtaining a BP of <140/90. Sixty-seven adults self-described as having high BP were analyzed. BP was measured at baseline and every 5 minutes for 15 minutes with the initial reading compared to the average of the last three readings (OBP-15). Compared to baseline, there was a decline in both average systolic (4.2 points) and diastolic (2.8 points) BP. The probability of BP control predicted by multivariate model was 71.6% at baseline and 78.0% using OBP-15 (p=0.011). The increase in BP control from initial to OBP-15 measurement was significant for indigenous or persons of color compared to whites, and men compared to women. OBP-15 is convenient and results in lower BP readings and higher probability of BP control compared to the initial reading.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10939486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140145029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
More Insights Regarding a Global Pharmacy Council. 关于全球药房委员会的更多见解。
Pub Date : 2023-10-10 eCollection Date: 2023-01-01 DOI: 10.24926/iip.v14i2.4803
Dominique Jordan, Catherine Duggan
{"title":"More Insights Regarding a Global Pharmacy Council.","authors":"Dominique Jordan, Catherine Duggan","doi":"10.24926/iip.v14i2.4803","DOIUrl":"https://doi.org/10.24926/iip.v14i2.4803","url":null,"abstract":"","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Training and Education Requirements for Pharmacists in Zero Gravity Environments. 零重力环境下药师的培训与教育要求
Pub Date : 2023-10-10 eCollection Date: 2023-01-01 DOI: 10.24926/iip.v14i2.5540
Muhammad Ahmer Raza
Dear Editor, I am writing to address the critical issue of training and education requirements for pharmacists working in zero gravity environments. With the advancement of space exploration and the potential for long-duration missions , it is crucial to equip pharmacists with the specialized knowledge and skills needed to provide pharmaceutical care in this unique setting. In this letter, I will discuss future potential roles of pharmacist in space, present a table outlining the necessary training areas for pharmacists working in zero gravity environments, address unique challenges, provide recommendations and propose solutions for creating a supportive ecosystem of pharmacy in zero gravity environments.
{"title":"Training and Education Requirements for Pharmacists in Zero Gravity Environments.","authors":"Muhammad Ahmer Raza","doi":"10.24926/iip.v14i2.5540","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5540","url":null,"abstract":"Dear Editor, I am writing to address the critical issue of training and education requirements for pharmacists working in zero gravity environments. With the advancement of space exploration and the potential for long-duration missions , it is crucial to equip pharmacists with the specialized knowledge and skills needed to provide pharmaceutical care in this unique setting. In this letter, I will discuss future potential roles of pharmacist in space, present a table outlining the necessary training areas for pharmacists working in zero gravity environments, address unique challenges, provide recommendations and propose solutions for creating a supportive ecosystem of pharmacy in zero gravity environments.","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of an interdisciplinary patient care model and routine screening on clinical outcomes in patients with hepatitis C. 跨学科患者护理模式和常规筛查对丙型肝炎患者临床结局的影响。
Pub Date : 2023-10-10 eCollection Date: 2023-01-01 DOI: 10.24926/iip.v14i2.5114
Vincent Lam, Christine Dimaculangan

Testing for hepatitis C in hospital emergency departments (ED) and linkage to care to clinics have been reported to provide the most opportunity for screening patients and facilitating continuum of care. Treatment model initiatives have expanded to include telehealth services and open treatment capacity to non-physician providers, such as pharmacists. This study's objective was to assess the impact of implementing automated routine screening for hepatitis C virus (HCV) and a clinical pharmacist into the interdisciplinary care model on HCV diagnosis and treatment outcomes. This retrospective cohort study compared outcomes in a pre-intervention and post-intervention group. Patients were screened and diagnosed with HCV at Jersey City Medical Center (JCMC) and completed linkage to care at JCMC Center for Comprehensive Care. Interventions were the implementation of automated routine HCV screening in the ED and addition of a clinical pharmacist to the interdisciplinary patient care model. Primary endpoints analyzed the number of patients who have achieved sustained virologic response after 12 weeks of treatment (SVR12) and patients who have completed treatment with no reported record of SVR12. Secondary endpoints analyzed the number of patients lost to follow-up, appointment type, time spent in appointments, and clinical pharmacist specialist interventions. Data was collected as categorical variables and chi-squared tests assessed if there were differences between the two samples. Data was collected from 46 patients in the pre-intervention group and 37 patients in the post-intervention group. Patients consisted of mostly males. Ages ranged from 27 to 83 years old. Race included Black, White, Asian, and Other. This study's results showed the positive impact on implementation of routine screening, telehealth services, and an interdisciplinary team approach to HCV diagnosis and management. Given the timeframe, it also showed the potential positive impact on these interventions during a global pandemic.

据报道,医院急诊科(ED)的丙型肝炎检测和与诊所的护理联系为筛查患者和促进持续护理提供了最大的机会。治疗模式举措已扩大到包括远程保健服务和向药剂师等非医生提供者开放治疗能力。本研究的目的是评估实施丙型肝炎病毒(HCV)自动常规筛查和临床药师纳入跨学科护理模式对HCV诊断和治疗结果的影响。这项回顾性队列研究比较了干预前组和干预后组的结果。患者在泽西城医疗中心(JCMC)进行筛查和诊断为HCV,并完成与JCMC综合护理中心的联系。干预措施是在急诊科实施自动常规HCV筛查,并在跨学科患者护理模式中增加临床药剂师。主要终点分析了治疗12周后达到持续病毒学应答(SVR12)的患者数量,以及完成治疗但未报告SVR12记录的患者数量。次要终点分析了失去随访的患者数量、预约类型、预约时间和临床药剂师专家干预。数据作为分类变量收集,卡方检验评估两个样本之间是否存在差异。数据来自干预前组46例患者和干预后组37例患者。患者以男性为主。年龄从27岁到83岁不等。种族包括黑人、白人、亚洲人和其他种族。这项研究的结果显示了对实施常规筛查、远程医疗服务和HCV诊断和管理的跨学科团队方法的积极影响。考虑到时间范围,它还显示了在全球大流行期间对这些干预措施的潜在积极影响。
{"title":"Impact of an interdisciplinary patient care model and routine screening on clinical outcomes in patients with hepatitis C.","authors":"Vincent Lam, Christine Dimaculangan","doi":"10.24926/iip.v14i2.5114","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5114","url":null,"abstract":"<p><p>Testing for hepatitis C in hospital emergency departments (ED) and linkage to care to clinics have been reported to provide the most opportunity for screening patients and facilitating continuum of care. Treatment model initiatives have expanded to include telehealth services and open treatment capacity to non-physician providers, such as pharmacists. This study's objective was to assess the impact of implementing automated routine screening for hepatitis C virus (HCV) and a clinical pharmacist into the interdisciplinary care model on HCV diagnosis and treatment outcomes. This retrospective cohort study compared outcomes in a pre-intervention and post-intervention group. Patients were screened and diagnosed with HCV at Jersey City Medical Center (JCMC) and completed linkage to care at JCMC Center for Comprehensive Care. Interventions were the implementation of automated routine HCV screening in the ED and addition of a clinical pharmacist to the interdisciplinary patient care model. Primary endpoints analyzed the number of patients who have achieved sustained virologic response after 12 weeks of treatment (SVR12) and patients who have completed treatment with no reported record of SVR12. Secondary endpoints analyzed the number of patients lost to follow-up, appointment type, time spent in appointments, and clinical pharmacist specialist interventions. Data was collected as categorical variables and chi-squared tests assessed if there were differences between the two samples. Data was collected from 46 patients in the pre-intervention group and 37 patients in the post-intervention group. Patients consisted of mostly males. Ages ranged from 27 to 83 years old. Race included Black, White, Asian, and Other. This study's results showed the positive impact on implementation of routine screening, telehealth services, and an interdisciplinary team approach to HCV diagnosis and management. Given the timeframe, it also showed the potential positive impact on these interventions during a global pandemic.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solutions for Atrial Fibrillation Edvocacy (SAFE): Improving Awareness And Access To Afib Screening For Detection And Referral For Treatment. 房颤宣传(SAFE)的解决方案:提高对房颤筛查的认识和获取,以发现和转诊治疗。
Pub Date : 2023-10-10 eCollection Date: 2023-01-01 DOI: 10.24926/iip.v14i2.5477
Jonathan Little, Aaron J Bonham, Benjamin M Bluml

Background: Atrial Fibrillation (Afib) can lead to stroke and heart failure, and early detection of Afib is an effective method of preventing these life-threatening conditions. An estimated 2.7 million Americans are living with Afib1, a number that is expected to rise dramatically in the coming years. Methods: The aim of this demonstration project was to create an additional access point in the community at local pharmacies for Afib screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate. This prospective research study was conducted with 14 community pharmacies across the US, in which a total of 650 patients were screened for Afib. Pharmacists conducted SAFEty Risk Assessments that consisted of completion of a Stroke Risk Scorecard and EKG determination utilizing AliveCor's KardiaMobile® 6L device. Results: In 552 (82.5%) of 669 total EKG readings, a "normal" rhythm was detected, and in 117 (17.5%) EKG readings an abnormal detection occurred. A total of 12 out of 650 patients (1.8%) received EKG readings of Afib, which is greater than double the expected prevalence of Afib in the US (0.81%), a statistically significant finding (p < 0.0001). Other notable findings included 42 (6.3%) EKG readings of Wide QRS, and 26 (3.9%) EKG readings of tachycardia. A total of 44 patients were referred to physicians for follow-up on their risk for Afib. Conclusions: Community pharmacies offer a unique, valuable access point for patients to receive Afib screenings. Pharmacists are well positioned to make a significant contribution in the cardiovascular health of their patients and increase the value of team-based health care.

背景:房颤(Afib)可导致中风和心力衰竭,早期发现房颤是预防这些危及生命的疾病的有效方法。估计有270万美国人患有Afib1,预计这一数字在未来几年将急剧上升。方法:该示范项目的目的是在社区的当地药房建立一个额外的接入点,用于Afib筛查、检测,并在适当的时候转介给医生进行随访和启动循证治疗。这项前瞻性研究是在美国的14家社区药店进行的,其中共有650名患者接受了Afib筛查。药剂师进行了安全风险评估,包括使用AliveCor的KardiaMobile®6L设备完成卒中风险记分卡和心电图测定。结果:669个心电图读数中有552个(82.5%)显示心律正常,117个(17.5%)心电图读数出现异常。650例患者中有12例(1.8%)接受了Afib的心电图读数,这是Afib在美国预期患病率(0.81%)的两倍以上,这是一个具有统计学意义的发现(p < 0.0001)。其他值得注意的发现包括42例(6.3%)宽QRS心电图读数和26例(3.9%)心动过速心电图读数。共有44名患者被转诊到医生那里随访他们患Afib的风险。结论:社区药房为接受心房颤动筛查的患者提供了一个独特的、有价值的接入点。药师可以在患者心血管健康方面做出重大贡献,并增加团队医疗保健的价值。
{"title":"Solutions for Atrial Fibrillation Edvocacy (SAFE): Improving Awareness And Access To Afib Screening For Detection And Referral For Treatment.","authors":"Jonathan Little, Aaron J Bonham, Benjamin M Bluml","doi":"10.24926/iip.v14i2.5477","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5477","url":null,"abstract":"<p><p><b>Background:</b> Atrial Fibrillation (Afib) can lead to stroke and heart failure, and early detection of Afib is an effective method of preventing these life-threatening conditions. An estimated 2.7 million Americans are living with Afib<sup>1</sup>, a number that is expected to rise dramatically in the coming years. <b>Methods:</b> The aim of this demonstration project was to create an additional access point in the community at local pharmacies for Afib screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate. This prospective research study was conducted with 14 community pharmacies across the US, in which a total of 650 patients were screened for Afib. Pharmacists conducted SAFEty Risk Assessments that consisted of completion of a Stroke Risk Scorecard and EKG determination utilizing AliveCor's KardiaMobile<sup>®</sup> 6L device. <b>Results:</b> In 552 (82.5%) of 669 total EKG readings, a \"normal\" rhythm was detected, and in 117 (17.5%) EKG readings an abnormal detection occurred. A total of 12 out of 650 patients (1.8%) received EKG readings of Afib, which is greater than double the expected prevalence of Afib in the US (0.81%), a statistically significant finding (p < 0.0001). Other notable findings included 42 (6.3%) EKG readings of Wide QRS, and 26 (3.9%) EKG readings of tachycardia. A total of 44 patients were referred to physicians for follow-up on their risk for Afib. <b>Conclusions:</b> Community pharmacies offer a unique, valuable access point for patients to receive Afib screenings. Pharmacists are well positioned to make a significant contribution in the cardiovascular health of their patients and increase the value of team-based health care.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Patient Education Game Design Activity. 病人教育游戏设计活动的评价
Pub Date : 2023-10-10 eCollection Date: 2023-01-01 DOI: 10.24926/iip.v14i2.5019
Andrea L Porter, Olivia Kim, Olufunmilola Abraham

Background: Game-based learning has been used in pharmacy education settings with the instructor developing a game for students to play to enhance learning. However, there is a paucity of data about health sciences students designing a game themselves to further their understanding of a complex topic. The purpose of this study was to describe and assess a game design activity focused on patient education of anticoagulants in a pharmacotherapy skills laboratory setting.

Innovation: Second-year pharmacy students enrolled in a pharmacotherapy skills laboratory course worked in teams in a one-hour active learning activity to design a game intended to educate patients about their medication. A pre/post analysis of student attitudes about game-based learning and the activity, as well as knowledge, was conducted.

Findings: The large majority of students (80.5%) agreed that the activity was an effective way to develop patient education strategies. Through the survey and free-response questions, students reported that the game design activity facilitated positive group collaboration and allowed students to take the perspective of their patients. Students also requested additional time to complete the activity. Knowledge assessment scores of key patient education points increased from 66.5% prior to the activity to 71.5% one week following the activity (p<0.05).

Conclusion: The game design activity served as a novel teaching method for pharmacy students to actively learn about anticoagulant medications while developing an innovative patient education strategy. Although there was an increase in knowledge scores, students highlighted the impact on group collaboration and taking the perspective of their patients.

背景:以游戏为基础的学习已经在药学教育中使用,教师为学生开发一个游戏来促进学习。然而,关于健康科学专业的学生自己设计游戏以进一步理解复杂主题的数据却很少。本研究的目的是描述和评估一个专注于药物治疗技能实验室环境中抗凝血剂患者教育的游戏设计活动。创新:参加药物治疗技能实验室课程的二年级药学学生以小组形式进行一小时的主动学习活动,设计一款旨在向患者传授药物知识的游戏。对学生对游戏学习、活动和知识的态度进行了前后分析。结果:绝大多数学生(80.5%)认为该活动是制定患者教育策略的有效途径。通过调查和自由回答问题,学生们报告说,游戏设计活动促进了积极的小组合作,并允许学生从病人的角度出发。学生们还要求额外的时间来完成活动。患者教育重点知识点的知识评估得分从活动前的66.5%提高到活动后一周的71.5%(结论:游戏设计活动为药学学生主动学习抗凝药物提供了一种新颖的教学方法,同时制定了创新的患者教育策略。虽然知识得分有所提高,但学生们强调了对小组合作和站在病人的角度考虑问题的影响。
{"title":"Evaluation of a Patient Education Game Design Activity.","authors":"Andrea L Porter, Olivia Kim, Olufunmilola Abraham","doi":"10.24926/iip.v14i2.5019","DOIUrl":"https://doi.org/10.24926/iip.v14i2.5019","url":null,"abstract":"<p><strong>Background: </strong>Game-based learning has been used in pharmacy education settings with the instructor developing a game for students to play to enhance learning. However, there is a paucity of data about health sciences students designing a game themselves to further their understanding of a complex topic. The purpose of this study was to describe and assess a game design activity focused on patient education of anticoagulants in a pharmacotherapy skills laboratory setting.</p><p><strong>Innovation: </strong>Second-year pharmacy students enrolled in a pharmacotherapy skills laboratory course worked in teams in a one-hour active learning activity to design a game intended to educate patients about their medication. A pre/post analysis of student attitudes about game-based learning and the activity, as well as knowledge, was conducted.</p><p><strong>Findings: </strong>The large majority of students (80.5%) agreed that the activity was an effective way to develop patient education strategies. Through the survey and free-response questions, students reported that the game design activity facilitated positive group collaboration and allowed students to take the perspective of their patients. Students also requested additional time to complete the activity. Knowledge assessment scores of key patient education points increased from 66.5% prior to the activity to 71.5% one week following the activity (p<0.05).</p><p><strong>Conclusion: </strong>The game design activity served as a novel teaching method for pharmacy students to actively learn about anticoagulant medications while developing an innovative patient education strategy. Although there was an increase in knowledge scores, students highlighted the impact on group collaboration and taking the perspective of their patients.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Innovations in pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1